
“Medexus Reports Impressive Fiscal Q3 2025 Results and Prepares for Launch of GRAFAPEX in the US Market”
Medexus Pharmaceuticals Announces Fiscal Q3 2025 Results Financial Performance Medexus Pharmaceuticals reported a strong financial performance for its third fiscal quarter of 2025. The company posted revenue of $30.0 million, with a net income of $0.7 million and operating income of $3.8 million. Adjusted EBITDA was reported at $5.8 million, showcasing the company’s profitability and…